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Background: Members of the transgender community have identified healthcare access barriers, yet a corresponding
inquiry into healthcare provider perspectives has lagged. Our aim was to examine physician perceptions of barriers to
healthcare provision for transgender patients.
Methods: This was a qualitative study with physician participants from Ontario, Canada. Semi-structured interviews were
used to capture a progression of ideas related to barriers faced by physicians when caring for trans patients. Qualitative
data were then transcribed verbatim and analysed with an emergent grounded theory approach.
Results: A total of thirteen (13) physician participants were interviewed. Analysis revealed healthcare barriers that grouped
into five themes: Accessing resources, medical knowledge deficits, ethics of transition-related medical care, diagnosing vs.
pathologising trans patients, and health system determinants. A centralising theme of “not knowing where to go or who
to talk to” was also identified.
Conclusions: The findings of this study show that physicians perceive barriers to the care of trans patients, and
that these barriers are multifactorial. Access barriers impede physicians when referring patients to specialists or
searching for reliable treatment information. Clinical management of trans patients is complicated by a lack of
knowledge, and by ethical considerations regarding treatments—which can be unfamiliar or challenging to
physicians. The disciplinary division of responsibilities within medicine further complicates care; few practitioners
identify trans healthcare as an interest area, and there is a tendency to overemphasise trans status in mental
health evaluations. Failure to recognise and accommodate trans patients within sex-segregated healthcare
systems leads to deficient health policy. The findings of this study suggest potential solutions to trans healthcare
barriers at the informational level—with increased awareness of clinical guidelines and by including trans health
issues in medical education—and at the institutional level, with support for both trans-focused and trans-friendly
primary care models.Background
Transgender and transsexual (trans) people continue to
experience discrimination, even in societies with advanced
human rights protections. The social marginalisation of
trans people is the focus of a growing body of scholarly
work that draws attention to discrimination in employment,
education, income, and housing [1-3]. Research shows that
transphobia—the experience of discrimination based on* Correspondence: jsnelgrove2011@meds.uwo.ca
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reproduction in any medium, provided the orhaving a gender identity or expression that varies from the
sex assigned at birth—also constitutes an access barrier to
medical care, both in general primary care [4-6], and in
specialised areas such as mental health [7], substance abuse
treatment [8], and HIV [9,10]. Barriers to access are
multifactorial, and although contributing issues include
frank discrimination such as verbal abuse, other more subtle
processes create environments that are ill adapted to the
needs of trans patients. Lack of knowledgeable healthcare
providers and medical information regarding trans
healthcare are cited as restrictions for trans patients seekingral Ltd. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly cited.
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the institutional level, where policies to accommodate trans
patients are absent, or the very need for these policies goes
unrecognised. Examples include the inability to schedule a
hysterectomy for a trans male, or the refusal to
accommodate in-patient placement consistent with a
patient’s expressed gender at an institution with separate
male and female wards. The concept of “erasure”—the
systematic deficiency in acknowledging and validating trans
identities, bodies, and experiences—provides a theoretical
base to consider the informational and institutional
processes through which healthcare barriers arise [13,14].
Erasure in healthcare settings may be propagated by the
lack of organised services addressing trans patients’ needs.
Even medical services directed at broader lesbian, gay,
bisexual, and transgender (LGBT) populations may fail to
properly accommodate trans patients [1,5,9,13]. This
contributes to an emerging debate regarding the optimal
organisation of trans medical care, particularly among
primary care services. Some previous work on trans health-
care needs has favoured a “trans-focused” care model, with
physicians and healthcare professionals specifically trained
in services directed at a trans patient population [5,6,9,11].
Others have suggested that trans healthcare might well fit
into existing generalised primary care models adapted to be
“trans-friendly” [6,10,12,15].
In Canada, healthcare delivery is covered by 13 provincial
or territorial health insurance programs [16]. These
insurance programs are publicly funded, with each health
insurance program federally mandated to provide essential
medical services. Additional covered medical services vary
between provinces, with private insurance available for
“non-essential” services. Trans healthcare services are not
formally organised in the province of Ontario, except with
respect to sex reassignment surgeries (SRS). SRS were re-
listed as publicly funded procedures in 2008 following a
ten-year delisting period, with a planned increase in the
number of provincial assessment centres authorised to
provide referrals [17]. These policy-based initiatives signify
that the Ontario government recognises sex transitioning
treatments as medically necessary services, although access
within the province may remain a challenge, especially
outside of large urban centres. Additionally, access is not
uniform across Canada. For example, the province of
Alberta delisted SRS as covered procedures in 2009, and
will only finance surgery for patients who had already
commenced the assessment process [18,19]. Other aspects
of trans healthcare, including medical transitioning
treatments and non-transition related care, are not
uniformly organised in Ontario.
Systematic deficiencies in addressing trans peoples’ needs
may contribute to social erasure of trans bodies, with the
structuring of healthcare delivery playing a significant role
in how governments recognise and accommodate transpatients. Additionally, the way in which medical and mental
health professionals identify and acknowledge transgender-
ism might further propagate healthcare access barriers for
trans people. These barriers arise when eligibility criteria for
specific treatments are based on a specific diagnosis, and
also when patients perceive discordance between their lived
experiences and a nosological interpretation of these
experiences as a medical or mental disorder. In Canada, the
tool used predominantly by psychiatrists and other
physicians to guide diagnosis of mental health conditions is
the Diagnostic and Statistical Manual of Mental Disorders
(DSM), currently available as a text-revised fourth edition
[20]. Transgender patients generally receive the diagnosis of
gender identity disorder (GID), which is defined as a strong,
consistent cross-gender identification accompanied by
persistent discomfort with the assigned sex that is not based
solely on a perceived cultural advantage of adopting the
opposite sex, and not better explained by other psychiatric
diagnoses [20]. Some researchers and members of the trans
community have challenged the nosological premise that
transgender identity represents psychiatric pathology. Lev
(2005) describes how the DSM does not allow for a healthy,
functioning variant of transgenderism, and only categorises
transgender experience in the context of dysfunction [21].
Additional concerns relate to the practice of establishing
GID as a precondition for medical treatment [4]. Dominant
narratives of transgender experience are reinforced by the
DSM criteria for GID, but these exclude other gender
variant individuals for whom transitioning treatment may
be of benefit. An ethical implication extending from this is
the possibility that patients feel compelled to provide
disingenuous histories of their transgender identity in order
to ensure treatment, should their actual experiences not
align with GID criteria [21,22]. The GID diagnosis often
forms a part of medical and surgical transition related care,
and may also influence how physicians and healthcare
professionals provide non-transition care to trans patients.
A formal diagnosis of GID is not considered an absolute
requirement to initiate sex transitioning therapy in clinical
guidelines [23-25]. Nonetheless, sex transitioning therapies
are generally preceded by a GID diagnosis [24], and clinical
guidelines do advise assessment of readiness to transition
by a clinician with competency in mental health [23-25].
For this reason, the interaction between psychiatrists and
the mental health system and physicians in other medical
fields becomes important when considering healthcare
barriers for trans patients.
Despite a broadening literature on healthcare barriers as
identified by members of the trans community, a corre-
sponding inquiry into healthcare provider perspectives has
not been assembled. Provider perspectives do not necessar-
ily align with those of service users, and expectations
regarding the accessibility of healthcare and the outcomes
of medical treatment may be dissimilar between these two
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information about barriers to the provision of medical care
for trans patients. Preliminary work suggests that lack of
training, limited medical knowledge, and scant access to
information sources are likely contributors to physician-side
healthcare provision barriers [13,28]. Some work has been
done to address medical knowledge gaps in the
management of care for trans patients. Canadian guidelines
have been published by Toronto’s Sherbourne Health
Centre and Vancouver Coastal Health, both of which cover
the dosing, contraindications, and monitoring of hormone
therapy in primary care settings [23,24]. Internationally, the
World Professional Association for Transgender Health
(WPATH, formerly the Harry Benjamin International
Gender Dysphoria Association) articulates standards of care
which are considered the touchstone professional consensus
around management of GID [25]. The WPATH standards
set out guidelines for diagnostic assessment, psychotherapy,
real-life experience, hormone therapy, and surgical therapy
[25]. Real-life experience in the subjective gender is
considered with reference to the social roles occupied by
the individual in their vocational/educational, recreational,
and family life, and the legal status of their name and
gender. Parameters are given for evaluating how well a
patient will adapt to their subjective gender [25].
Previous work has suggested that physician-side
barriers to healthcare for trans patients include issues
surrounding medical knowledge, the role of mental
health services and GID diagnosis, and the organisation
of health systems. The aim of this project was to expand
the current literature by examining these and other
barriers to healthcare provision faced by physicians when
caring for trans patients. Our objective was to undertake
an exploratory analysis of what these physician-side
barriers are, and how they may begin to be addressed.
Methods
This study was conducted using a qualitative approach
based on grounded theory to explore physician perceptions
and experiences. Grounded theory allows for the inductive
generation of theoretical frameworks through systematic
collection and analysis of qualitative data [29,30]. This
methodology was considered appropriate because little is
known empirically or from theory about physician
perceptions of barriers to care for trans patients.
Participant recruitment for the study initially used
purposive sampling to identify physicians in Southwestern
or Southern Ontario, Canada. Given the exploratory nature
of this study, practitioners from both general and speciality
backgrounds were included rather than focussing on
identifying issues specific to any one discipline. Physicians
with little or no known contact with trans patients were not
excluded from the study. Trans patients come into contact
with physicians from various clinical backgrounds, andphysicians without prior trans exposure may perceive care
provision barriers that differ in important ways from those
with trans patient exposure. Physicians with a potential
interest in trans health issues or an openness to accommo-
dating trans patients in their practice were also identified by
non-medical contacts at a Southwestern Ontario trans
support group. Additional participants were solicited during
interviews using a snowball sampling approach, as
physicians who deliver healthcare services to trans patients
might be considered knowledgeable about colleagues with
similar practice interests. After an initial iteration of data
collection and analysis, we sought further participation
using Glaser and Strauss’s concept of theoretical sampling
[29]. The purpose of theoretical sampling is to provide
deeper understanding of a concept under investigation. This
allows for elaboration on concepts and themes in the
development of a robust analytical frame—a process which
ideally results in theoretical saturation of the overall
conceptual framework [29,31]. In practical terms, this
involved the recruitment of physicians in obstetrics and
gynaecology, psychiatry, and endocrinology to elaborate on
emerging themes that were underdeveloped, as trans
patients are often referred to these specialists during
medical transitioning. Recruitment was stopped once data
phrases no longer contributed novel themes or ideas to the
analytical categories.
Individual interviews were conducted by telephone or
in person by one of four medical student researchers.
We used a semi-structured interview template (Additional
file 1) and interviewers prompted for elaboration during
interview sessions, but focused on physicians’ responses in
the context of their own interpretation of the issue. Semi-
structured interviews were chosen to allow for a natural
progression of ideas and because the chief interest of the
study was perceptions and experiences of individual
practising physicians. Interviews were audio-recorded and
transcribed verbatim, with personal identifiers removed. A
participant’s gender and medical specialty were reported
and linked with quotation excerpts following their consent.
Informed consent was obtained in writing for in-person
interviews and verbally recorded for telephone interviews.
Participants were informed that they could withdraw
consent to participate at any time during the interview or
thereafter should they choose.
Transcript files were imported to an open-source qualita-
tive analysis program, Weft QDA 1.01 (www.pressure.to/
qda/) for analysis. Data phrases from interviews encompass-
ing a complete concept or idea were tagged. We then coded
these data phrases using an emergent approach [31].
Thematic areas were identified on a continual basis,
whereby categories were compared and grouped with one
another. Data phrases that articulated contrasting opinions
about the same topic became incorporated into the same
category to capture a breadth of perspective. Results were
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University of Western Ontario Ethics Review Board
provided ethical approval for this project. The study design




Thirteen (13) physicians participated in this study. The
majority (9) were general practitioners, with practice
characteristics ranging from comprehensive family
medicine to population-specific LGBT health and HIV
care. The remaining participants practised in the specialties
of obstetrics and gynaecology, endocrinology, nuclear
medicine, and psychiatry. The geographical distribution of
participants was focused in urban and small-city settings,
although two had rural practices. Approximately half were
affiliated with an academic centre. Participants ranged in
age from 29 to 57. Seven (7) identified as male and
six (6) as female; none identified as transgender. Five
(5) participants had no known experience directly
caring for a trans patient, and five (5) had up to five
trans patients in their practice at the time of
interview. Three (3) participants—one psychiatrist and
two family physicians—described trans patients as a
significant proportion of their practice population.
Participants who knowingly had contact with a trans
patient in their practice were able to offer more
complex accounts of care barriers than those without
similar exposures. This reinforced the observation that
contact with a trans patient provides an instigating
event for physician reflection and education on the
healthcare needs of this patient group.
A centralising theory: “Didn't know where to go or who to
talk to”
Physicians commonly identified barriers to care provision in
the context of not knowing the available resources or care
strategies appropriate for the trans patient population. This
overarching concept persisted across other major themes
and provided a focus for the analysis. Participants with no
experience caring for trans patients as well as those with ex-
perience expressed similar concerns, as demonstrated re-
spectively in the following excerpts.
"I have wondered if a patient like that [trans] was to
come along what I would do. And the answer is I have
no idea. . . I mean if a patient was looking for sex
reassignment surgery or something along those lines, I
would have no idea who to send them to." Dr. T, family
physician, male.
“. . .despite trying to find ways to improve my
expertise, I just didn’t know where to go or who totalk to, or where to get the information, and I felt
really bad because some of my initial attempts to help
these people—I sent them to people I wish I hadn’t
sent them to.” Dr. S, family/HIV primary care
physician, male.
Categories that emerged during the analysis elaborated
on the barriers physicians face when providing care to
trans patients. These categories clustered into five (5)
related but distinct thematic areas: accessing resources,
medical knowledge deficits, ethics of transition-related
medical care, diagnosing vs. pathologising trans identity,
and health system determinants.
Accessing resources
A major barrier to healthcare provision was the
identification, availability, and quality of referral
networks and information sources regarding trans
medical care. Identifying “trans-friendly” colleagues for
referral outside of one’s scope of practice was difficult,
both for lack of knowledge regarding specialist availability,
and for concern regarding colleagues’ sensitivity. SRS
referrals were chiefly concerning given the highly specialised
skill set required for these therapies. Depending on the
procedure, surgeons capable of performing SRS may not be
available regionally, forcing referring physicians to consider
alternative options.
“I have felt completely out-at-sea without a life
preserver in terms of trying to find physicians, both
nationally and internationally, who can assist in terms
of their surgical transition.” Dr. S, family/HIV primary
care physician, male.
Reasons for insensitivity toward trans people were
understood mainly in moral terms—recognising that some
physicians could have entrenched personal beliefs about
gender identity, sexuality, and sexual health that are at odds
with trans patients’ lives. Participants varied in how they
characterised these biases, but most described physicians’
comfort with trans people in dichotomised terms.
“Doctors can kind of go two ways right? You can either
see a whole bunch of life and decide that there’s no point
in being judgmental—everyone’s different and, you know,
everyone’s got their own path in life and not to judge
people—or you can just get really narrow-minded and
somehow build this construct between ‘us’ and ‘them’,
with ‘them’ being the patients.” Dr. W, family/HIV
primary care physician, male.
This reflected a general perception that certain clinicians
will be interested in trans healthcare and include this in
their practice, and other physicians will not. Physicians
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concerning colleagues’ sensitivity. In the “hit or miss”
approach, referrals were made based on patient care needs
without knowing how sensitive the consulted physician
would be. Alternatively, referrals were directed to physicians
with known interests in caring for sexual minorities, such
as physicians with large homosexual practice populations.
Patient feedback was an important determinant of future
referrals.
“But now, really throughout all the hospitals you
know, there’s good people there and it’s trial and error,
like you know you refer somebody and they come
back and say, ‘you know that guy was a total dickhead’
or ‘you know he treated me like I was from another
planet’ and so you just know not to refer to those
people again.” Dr. W, family/HIV primary care
physician, male.
The complexity of a physician’s referral strategy appeared
to be related to their level of experience in managing the
care of trans patients. Those with more familiarity in trans
healthcare referred patients to specific colleagues with
whom they had developed a working relationship.
Overwhelmingly, participants cited deficiencies in
informative sources regarding trans care management as a
substantial barrier to care. Most participants specified the
need for readily accessible information through efficient
media, such as the internet. The intended audience for
information sources was also considered, since physicians
may not consume information unless it is directed toward
them explicitly.
"It’s going to, however, have to be targeted to a
physician, because we need that. We need to feel that
we’re getting different information than the public."
Dr. A, obstetrician/gynaecologist, female.
Others suggested that the validity of information might
be judged by the media used to distribute it. Academic
journals, internet sites endorsed by a professional medical
organisation, and Continuing Medical Education (CME)
conferences were considered more appropriate sources than
general information found on the internet. One participant
noted that CME activities may be credited toward ongoing
license maintenance requirements. While still seen as
deficient, according to some participants the availability of
trans healthcare information has increased since entering
clinical practice.
Trans-specific medical knowledge deficits
Barriers concerning physicians’ clinical experiences with
trans patients mainly related to knowledge deficits. The
lack of advance exposure to trans patients preventedphysicians from acquiring clinical proficiency in trans
healthcare needs.
“I would imagine that the average physician, especially if
you’re a family doctor, has had no exposure to these sorts
of things. You know, the first time you get a
transgendered patient come into your office, you’re sort
of lost and you don’t really know what to do.” Dr. K,
nuclear medicine physician, male.
Additionally, formal education around trans healthcare
was described as absent from medical school and residency
curricula. Despite agreeing on the lack of trans-related
education, participants differed in opinion on strategies to
ameliorate training deficiencies. For some, medical school
education should incorporate issues pertaining to trans
healthcare.
“I think one issue that concerns me is the lack of
training and/or exposure that med students and
residents have to the transgendered population and
indeed the general population of people, you know
often will think that they’ve never met a trans person.
Well many of them have. So you know the feeling
that, ‘well this doesn’t affect my practice or my life,’
you know perpetuates the lack of, the idea that there’s
just no need for training around trans issues.” Dr. M,
family physician, female.
In contrast, the idea that medical school curricula
should focus on more commonly encountered conditions
was also presented, suggesting that transition-specific
medical care could be covered through clinical exposures
and supplemental learning opportunities based on the
individual interests or practice needs of physicians.
“I think at the level of medical school when you’re
trying to learn like this much [wide arm gesture], that,
you know, I’m not sure that it’s something there is
room for. . .
. . . I don’t know whether that’s the best use of time.
You always are going to learn more about what you
need to learn or want to learn. Just do the research.”
Dr. Y, family physician, female.
Four different strategies to ameliorate training deficiencies
emerged from the analysis. Three of these were discussed in
favourable terms: physician support networks, explorative
interest, and clinical guidelines. One additional strategy was
noted as an unfortunate consequence of few physicians
being comfortable managing trans healthcare, and detailed
how trans patients are often left to research referral and
treatment options for themselves.
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best to manage, and not that I’m adverse to that, I’m
really happy, but it was really the community themselves
who have nested and have isolated, you know, where
should somebody be sent under these circumstances,
where should they be sent for this issue. And so I really
appreciated that the community themselves have
mustered up that internal support and guide physicians,
but that’s pretty suboptimal when patients have to tell
doctors, you know, how to do what we should know how
to do.” Dr. S, family/HIV primary care physician, male.
Physicians compared the consultation support provided
for cardiac conditions and HIV care with what could be
established for trans healthcare needs. They suggested that
experts in the area could support colleagues with less
experience through physician networks. Another strategy
identified the potential for physicians to become more
informed through an explorative interest in the area. The
field of trans healthcare was seen to provide unique practice
opportunities for physicians, particularly in psychiatry and
endocrinology. Although a physician may not commonly
encounter trans healthcare issues, these are not necessarily
outside their scope of practice. An example of this was
given: endocrinology training in hormone replacement does
not usually include hormone therapy for trans patients, but
the knowledge base of an endocrinologist is sufficient to
accommodate trans patients requiring hormones for
transitioning. Lastly, clinical guidelines emerged as a
potential solution to knowledge deficits. Participants with
marginal or no experience caring for trans patients
identified the usefulness of these resources, but were
unaware of guidelines that are currently available.
“For physicians to have access to guidelines as to
therapy, hormonal therapy you know replacement
therapy but also, like I said, the interesting things
that you have to remember; For example, the prostate
may still be in place even though they’re now female,
and those kinds of things you need to remember.
And having some sort of guidelines for that I think
would be of real benefit.” Dr. L, endocrinologist,
female.
Participants with significant trans patient populations
mentioned existing guidelines for management of medical
transitioning, underscoring the importance of flexibility in
their application.
“The Harry Benjamin guidelines [WPATH guidelines]
are still like the key guidelines and, like I say they’re not a
bad starting point but you do have to add a bit of
common sense to it.” Dr. W, family/HIV primary care
physician, maleGuidelines themselves were seen to present potential
barriers when their criteria limited treatment options or
prolonged a patient’s treatment course unnecessarily. The
issue of “wait time” in medical transitioning was important
for participants experienced with hormonal therapy and
surgical referrals. They noted that guidelines can include a
chronological treatment framework. While this ensures
patient readiness for medical transitioning, the length of
wait time needed was seen to vary based on individual
patient factors. One participant noted that some physicians
follow chronological criteria exactly, while others take a
more flexible approach and initiate hormone treatment
earlier based on their clinical judgment.
Ethics of transition-related medical care
Participants with experience treating trans patients
identified several barriers related to the unique clinical
relationship between trans healthcare needs and the
medical system—the nature of which is distinct from those
of sexual minorities. Trans people often rely on hormones
and surgical procedures to reconcile their anatomy and
physiology with their gender identity, which relies to some
extent on medical access.
“Homosexuality doesn’t need medical treatment, unless
trauma because of experienced or internalised
homophobia, which of course needs treatment.
. . .But with gender identity, because it requires a physical
changing, it requires medical knowledge.” Dr. M, family
physician, female.
This unique relationship presents several key issues.
Given the importance of decisions surrounding medical
transitioning, physicians may feel uncomfortable influen-
cing a person’s choice to pursue treatment or not. This
can have little to do with a physician’s comfort with the
actual therapy and its monitoring, as illustrated by one
participant who regularly prescribes hormone treatments
for transitioning patients:
“I encourage everyone to explore their gender identity,
even people who are not transgender. However, I won’t
encourage anyone to transition physically, or to have
surgery, or to take hormones, or even to explore too
much more in depth their gender identity than makes
them comfortable.” Dr. M, family physician, female.
The reluctance to influence a patient’s decision to
undergo treatment was almost exclusively related to
concern that the patient may later regret their choice.
“I don’t like to deny treatment and sometimes if
somebody comes in and they give a very compelling
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transgender, then I don’t want to put obstacles up. But
on the other hand, you know one of my worst fears is
that somebody will regret their decision that I’ve taken
part in.” Dr. W, family/HIV primary care physician, male.
Participants also considered how the effects of hormone
treatment differ between genetic males and females; the
physiological consequences of masculinising hormones in
genetic females are less reversible than feminising
hormones in genetic males. Treatment regret also emerged
in a medico-legal context. Physicians were cognisant of the
legal ramifications of initiating therapy, potential side
effects, and the communication of patient information
between providers.
Patient expectations comprised a final barrier to
transition-related care. Physicians noted that patients might
have ideas about how they will feel and look after
transitioning that are unrealistic for various reasons.
"It’s like every teenage girl coming to me and saying
'Well, I want to look like Angelina Jolie' or every guy
saying they want to look like Brad Pitt. . . And those are
terribly unrealistic expectations people have of the
medical system. . . You know it’s a struggle for me to tell
people, 'No, you know, you shouldn’t be expecting this.'
And there are some people who are really out of touch
with reality around it because they have seen other people
transform themselves in such a drastic and a dramatic
way, however that may not be possible for everyone for
various reasons.” Dr. M, family physician, female.
Physicians may find it difficult to predict realistic treat-
ment outcomes, or to ensure a patient’s expectations can be
accommodated with the treatment being considered.
Unrealistic expectations among physician colleagues added
another obstacle to care. Even physicians with experience in
providing gender transitioning therapies may not appreciate
the variability of treatment outcomes.
Diagnosing vs. pathologising
Several participants expanded on the concept of
pathologising trans status—most notably through the
inclusion of GID in the DSM [20]. Four main issues
were identified. First, healthcare professionals often
confuse GID with other psychiatric diagnoses—the
paraphilia known as transvestic fetishism, for example.
The fact that the paraphilias also cover mental illnesses
predisposing an affected individual to criminal activity—
such as the case with paedophilia—was of particular
concern. A second issue was that providers often assume
trans patients have other psychiatric conditions, or that hav-
ing GID necessarily puts a patient at higher risk of other
mental illness."Most of them [trans patients] don't have any other
diagnoses and I think there's a misperception among a
lot of medical people—psychiatrists and others—that it's
so not within the normal range of what they understand
that they just assume that these folks must have other
significant pathologies, which is just not true." Dr. N,
psychiatrist, female.
A third issue related to accessing treatment for patients
who medically transition. Access to healthcare is historically
premised upon identifying a condition that requires
treatment. This has implications for the public funding of
recognised medical treatments and in identifying the
medical practitioners who should be responsible for the
care of certain populations. A potential benefit of including
trans identity in the DSM is that its codification makes it a
medically recognised condition requiring attention from
providers.
“I guess if you're removing something from the DSM,
well where are you going to put it so that people can still
get the services that they need—in this case, hormone
treatment and sex reassignment surgery? So who's going
to look after that, if not psychiatrists right? . . .So before
removing it [from the DSM], which I think should be
done at some point, I agree it pathologises what should
not be pathologised, but it's still something that requires
treatment, right? So who's going to do the treatment?
Which means the decision maker is not going to be a
psychiatrist. That would have to be worked out before it
would get removed.” Dr. N, psychiatrist, female.
A final consideration was how trans status—and GID
in particular—should be dealt with as a psychiatric
diagnosis. While participants generally agreed that a
trans identity is not itself pathological, its inclusion in
the DSM—and, broadly, its categorisation as a psychiatric
condition—evoked contrasting ideas.
"The best thing would be to . . . make it its own
category, and I would maybe call it ‘Core conditions
related to gender identity,’ which are generally not,
first of all, pathological." Dr. M, family physician,
female.
Some participants advocated for reclassification of GID
within the DSM, while an alternative opinion was that GID
should be removed from the DSM altogether.Health system determinants
The concept of “two-gender medicine” emerged to
characterise health system barriers. At the institutional
level, these barriers manifest as systematic failures in
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trans patients.
“. . .So I looked at this gentleman and thought, what
room am I going to put you in? Like, because if you’re in
a room with men—which you deserve to be—the nurse
is going to come in and ask you if you’re doing fine since
your hysterectomy. That’s not fair to him with the other
men in the room. So I said ‘You’ll have a private room,
regardless of what your health insurance says.’ So I can
do that for him, as a physician looking after him.” Dr. A,
obstetrician/gynaecologist, female.
Participants explained that sex-specific eligibility criteria
for certain procedures, screening tests, or therapies could
prevent adequate healthcare for trans patients. This
phenomenon was distinct from issues concerning clinician
experience or knowledge deficits. Rather, health system level
barriers exist when it is impossible or difficult to order a test
or therapy for a patient who is considered ineligible based
on their gender.
"If I had a transsexual who needs to get a prostate
ultrasound—so this is a born male but now is a female
transsexual—unfortunately, that can be problematic at
the lab doing the prostate ultrasound.” Dr. S, family/HIV
primary care physician, male.
Where care is not hindered outright by eligibility deficits,
limited care options remain a significant barrier. In the
context of medically transitioning sex, these barriers stem
from having few practitioners available to initiate and
monitor therapy, and from restricted management options
for transitioning. As an example of the former, one
participant described difficulty finding a urologist who
would perform an elective orchiectomy:
“This [trans female patient] started to have some
problems from [her] exogenous hormonal therapy and
[she] very appropriately elected to have an orchiectomy,
which would then circumvent the need for all these
exogenous hormones. I had difficulty finding a urologist
who would do an elective orchiectomy for this issue, but
eventual did find one.” Dr. S, family/HIV primary care
physician, male.
Regarding the latter, several participants described the
standardised protocols at the Centre for Addiction and
Mental Health (CAMH) in Toronto, Ontario, a facility
that provides assessment and referrals related to medical
and surgical transitioning. Participants noted that
healthcare providers might feel limited in the options
they can offer patients when a group standard is in place.
More concerning was the fact that some health institutesactively discouraged providers from using clinic time for
trans patients.
"I do have to do this after hours for a reason because
my employer, shall we say, would not allow me to
create the clinic I would like to create within the
hospital system, and so doing it on my own time is the
only way I can do that. . .
. . .So there's a lot of misunderstanding that way and a
lot of, I'd have to say transphobia and definitely
homophobia as well, when I suggested the idea of
having an LGBT clinic within my organisation. I was
told 'Well, you can do that quietly.' But you can't
create a program quietly." Dr. N, psychiatrist, female.
Participants acknowledged that even where specific
policies discriminating against trans patients are not in
place, the general attitude of an institution contributes
largely to care delivery at that site. Inadequate cultural
competence and restrictive policies—whether official or
not—were seen to contribute to systematic discrimination
and transphobia that manifest as barriers to care provision
at the institutional level.
The organisation of physician roles and responsibilities
was another element influencing health system level
barriers. Contrasting ideas were presented regarding the
responsibility of primary care physicians in trans patient
care. Some participants—particularly those in specialist
areas—expressed frustration that certain health services
which could be provided by primary care physicians are
not.
“There’s only one endocrinologist in the city that
prescribes hormones for transgendered individuals, so
the wait list to see that particular person is quite long. . .
and we don’t have a lot of family doctors in the city that I
know of that are willing to prescribe the hormones.
Certainly family doctors are capable if they have the
training and the knowledge, but some people are just not
interested in gaining that knowledge it seems, so that's a
bit frustrating. It's all gotten to the point where I've
thought about getting training, but unfortunately it
would probably not be a good idea for their psychiatrist
to be prescribing the hormones." Dr. N, psychiatrist,
female.
Service provision responsibilities were often seen to fall
under specific disciplines within the medical community.
However, some services—such as hormone therapy in the
preceding example—were considered by several participants
as appropriate for primary care physicians to provide,
despite also being covered under the practice scope of
specialists. A contrasting perspective was that primary care
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for more complicated management issues. The following
example demonstrates this point and how, for some
primary care physicians, hormone prescription might be
viewed as a more specialised service not to be provided
without specialist consultation.
“But it also comes from, you know, what do trans
patients need? You know if you’re not comfortable
doing the hormones you can always refer to an
endocrinologist. But apart from that what they need is
they need to have their blood pressure checked, if
they’re over 55 they need colonoscopies, they need
physicals once a year. . . They’re people right, first and
foremost they’re people. So you know, I’m not
comfortable dealing with complicated cardiac
arrhythmias or deciding to start people on
amiodarone. I don’t do that, so I refer that part to a
cardiologist and I take care of the rest of the person.
That’s what primary care does." Dr. W, family/HIV
primary care physician, male.
These divergent opinions reflected different expectations
regarding which services should be provided by the primary
care system. While it was generally recognised that family
medicine should encompass general care issues for any
patient—including trans patients—some participants
suggested that primary care services targeted specifically to
the trans population in a “trans-focused” care model would
be more effective. These participants reiterated that it may
be harder for trans patients to obtain appropriate care
under a generalised but “trans-friendly” primary care system
for reasons related to patient concerns, physician bias, and
other barriers described previously.
The unique position of psychiatry in addressing trans
healthcare needs emerged in two main areas: first, regarding
consultation prior to hormonal or surgical transitioning and
second, in instances where a patient with a mental illness
requires professional consultation and happens to be trans.
The role of the psychiatrist in the treatment consent
process was framed in non-exclusive terms. Other
physicians involved in the care of a trans patient may just as
appropriately assess patient competency in making
treatment decisions. However, in practice, physicians seem
reluctant to obtain consent without consulting psychiatric
services.
"And certainly, I can see why it's important to have a
psychiatrist rule out some specific conditions before
changes are made that are irreversible, such as hormone
treatments and gender reassignment surgery. I absolutely
understand why it's important to rule out some of those
things, but in terms of, you know, should psychiatry be
the only specialty that has the opportunity to say, 'Yes,this person should be qualified for the surgery?' Probably
not. I would imagine that endocrinologists, for example,
or even family doctors with special training could
probably make those kinds of decisions without a
psychiatrist. But we're not there yet." Dr. N, psychiatrist,
female.
The notion that gender identity constitutes a special
area of psychiatry was cited as a barrier, considering the
few psychiatrists who work in the area.
“So it’s even worse for transgender patients because
they’ve got to deal with the general shortage of
psychiatrists and a lack of funding for a broader
spectrum of psychological services. In addition, even if
they get in the door to see a psychiatrist, most
psychiatrists are going to say, 'Oh I don’t know how to
deal with this, you have to go and see the experts.'”
Dr. W, family/HIV primary care physician, male.
This became particularly important outside of
transitioning treatment, because gender identity was
described as overemphasised in the evaluation of trans
patients with a mental illness.
Discussion
The findings of this exploratory qualitative study show
that physicians perceive significant barriers when
providing healthcare services to trans patients. The
central theme that emerged emphasised uncertainty in
multiple areas of healthcare provision. Access barriers
impede physicians during patient referrals, and when
searching for reliable information. The clinical management
of trans patients is complicated by a lack of knowledge and
experience, and by ethical considerations regarding medical
transitioning treatments, which may be unfamiliar or
challenging to physicians. The process of diagnosing GID
might further complicate care, particularly regarding access
to transition-related treatments. At the health system level,
the disciplinary division of responsibilities in the medical
profession poses additional care barriers, and policy to
address healthcare service deficits is underdeveloped. While
significant barriers exist, participants in this study, from
various clinical backgrounds and practice settings, were able
to describe potential solutions. These included improved
sources of information (such as clinical guidelines),
increased dissemination of current guidelines, incorporation
of trans healthcare issues into medical curricula, better
collaboration with knowledgeable colleagues, and
policy-based initiatives to improve access to healthcare
services for trans patients.
This analysis suggests that the traditional referral
process used for specialist consultation contributes to
barriers in two main ways. First, physicians may have
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to address the clinical problem, or they may worry about
the sensitivity of colleagues when referring a trans patient
for specialist care. The patient-side literature on trans
healthcare barriers reflects a similar concern over limited
access to knowledgeable, sensitive clinicians [1,6-8]. Second,
relying too heavily on specialised services favours the notion
that trans patients comprise an exceptional subgroup, rather
than a primary care population with a set of care needs that
are not limited solely to medical transitioning. Physician
uncertainty with care options and referrals was usually
attributed to information deficits. Previous research has
shown that healthcare providers for LGBT patients have
unique informational needs, and desire access to reliable
LGBT specific resources [28]. The uncertainty of patient
satisfaction was an important element linking information
access and the ethics of transition-related care. Participants
with experience in gender transitioning treatments
expressed concern that patients may be unsatisfied with
results or, worse, altogether regret their decision to undergo
treatment. Perspectives from the trans community
demonstrate a similar concern over lack of information on
long-term outcomes and potential complications of gender
transitioning treatments [13]. The literature on patient
satisfaction after surgical transitioning is not extensive, but
suggests that patient regret is relatively minimal, with a
prevalence ranging from 2-6 % depending on the procedure
[33-35]. Clinical guidelines were seen as a way to address
knowledge deficits in gender transitioning treatments and
preventative screening, but were not without criticism. In
particular, the most recent WPATH standards at the time
of interviews suggest three months of real-life experience
before initiating hormone therapy [25], which is
problematic for patients who feel uncomfortable living in
their subjective gender without some of the physical
changes induced by therapy. However, guidelines do give
additional consideration to the initiation of therapy without
definitive GID diagnosis under a harm reduction model for
those who would otherwise use illicit hormones, and for
patients experiencing significant distress regarding their
gender presentation [23-25]. The availability of clinical
guidelines online has increased their accessibility, but more
work needs to be done promoting these resources among
clinicians. The formation of physician support networks
emerged as another solution, addressing issues with referral
and knowledge deficits. Informal networks already exist,
where primary care physicians have identified trans-
friendly specialist colleagues, and where rural physicians
have consulted urban colleagues with more experience
managing hormone therapy. However, a cohesive
professional network of physicians providing trans
healthcare does not yet exist in Ontario. Such a network
may reduce barriers related to the referral process by
making health services for trans patients less dispersedand increasingly available at one-stop clinic locations, a
concept that has been shown to appeal to the trans
community [1,5].
The interaction between gender identity and psychiatric
diagnosis became an important topic in the present study.
A shortage of physicians (psychiatrists and other)
competent in diagnosing GID contributes to treatment
delays and restrictions. Overall, participants in this study
recognised benefits and drawbacks to the inclusion of GID
as a mental health condition in the DSM. On the one hand,
the codification of transgender identity supports the
autonomy of patients by validating their gender experience
within the medical community, and by establishing
diagnostic criteria through which a person may access
treatment. On the other hand, the diagnosis of GID is
restrictive in its applicability to only dominant
transgender variants and pathologises transgender
experience as a disorder. Patient-side research has
likewise identified an overemphasis on trans status in
mental health evaluations of trans patients, and concern
about the “gatekeeper” role of mental health professionals
for access to transitioning treatment [1,4,13]. Participants
who discussed the role of diagnosis in gender transitioning
articulated these competing perspectives, but were in favour
of retaining some aspect of diagnosis. Previous work on
trans identity erasure provides insight for why this may be.
Namaste (2000) argues that the acceptance of psychiatry’s
role in classifying gender—for example, with the diagnosis
of GID—legitimises this discipline in both regulating and
defining transsexuality [14]. While this is problematic,
Namaste (2000) describes the potential for “reverse
discourse,” whereby trans individuals uptake the vocabulary
used to describe them in psychiatric and medical contexts
to organise for political resistance, or to advocate for certain
rights. An extension of this explains how acceptance of GID
as a psychiatric diagnosis may provide avenues for patients
to gain better access to healthcare. Dewey (2008) found that
trans patients supported the established discourse regarding
gender identity through the use of medical language in
attempts to access transitioning treatments. Use of medical
language has also allowed patients to engage in resistance
activity by challenging medical decisions [22]. Previous
work suggests that the process of diagnosis confers medical
legitimacy and advances the treatment needs of trans
patients as clinically necessary services rather than cosmetic
therapies [21,36]. Physicians might feel that a DSM
diagnosis offers greater likelihood of treatment accessibility
than alternative options, and the literature implies that in a
similar way, trans patients might support GID as a diagnosis
if it eases access to treatment. Notably, an updated fifth
edition of the DSM is scheduled for release in 2013, with
proposed changes to the name (from GID to gender
dysphoria) and diagnostic criteria for the condition [37].
These changes will likely advance a less pathologising
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whether changes to DSM criteria and diagnoses will be
reflected in clinical guidelines, or if the “gatekeeper” role of
psychiatry will change significantly for access to transition-
ing treatments. Of note, the recently revised WPATH
guidelines distinguish between gender dysphoria and gender
nonconformity and call for a “de-psychopathologisation” of
trans identity [38]. These revised guidelines became
available after the data collection for this study.
Access, sufficient medical knowledge, a thorough
understanding of potential ethical considerations, and
the issues associated with GID diagnosis all affect how
care is provided by physicians to trans patients. These
barriers also raise the issue of how service provision is
best modelled. In this study, a contrast emerged between
a trans-focused care model versus a trans-friendly—but
otherwise general—primary care model. Most
participants advocated for generalised competencies
under a “trans-friendly” model for trans medical
knowledge, the basics of medical transitioning
assessment and treatment, and overall healthcare issues
relevant to the trans population. However, this was not
unanimous. This contrast is reflected in the literature,
with arguments in favour of trans-focused care models
[5,6,9,11], and also generalised trans-friendly models
[6,10,12,15]. Part of the difference in opinion likely
relates to the complexity of trans patients’ healthcare
needs. This analysis found evidence that the
determinants of such needs extend beyond medicalised
distinctions separating “general” and “trans-specific”
healthcare issues. Although not direct barriers to
healthcare provision, participants recognised that social
inequalities, poor social support, and discrimination
unavoidably influence healthcare access for trans
patients. In this way, social exclusion propagates the
healthcare barriers experienced by trans patients. One
emergent concept characterised the trans community as
a “hidden population”—a group underestimated in size
and therefore underrepresented in social spaces. Several
participants correlated the lack of knowledge in trans
healthcare with the relative obscurity of trans identities
within the general population. While trans individuals
undoubtedly represent a minority, existing population
estimates are considered inaccurately low [13,39], and a
recent U.S. estimate posited that 0.3 % of adults are
transgender [40]. The assumption that most physicians
will never encounter a trans patient contributes to
informational erasure, whereby the need for healthcare
training, research, and policies inclusive of trans people
is systematically unrecognised [13]. In consideration of
this, several participants advocated for inclusion of trans
healthcare topics in medical curricula, or introducing
medical students to trans people early-on during their
education. These strategies, and improved familiarity withexisting clinical guidelines, could address healthcare barriers
by normalising trans identity amongst medical trainees.
Other participants described the “hidden population”
phenomenon differently, suggesting that clinical encounters
with trans patients are more common than generally
acknowledged, but for various reasons, trans patients may
be unwilling to disclose their transition history to
physicians. The literature on trans patients’ experiences
with healthcare professionals offers insight into the factors
that promote or discourage openness about gender identity.
A holistic approach to medical care, perceived interest in
patient wellbeing, and the ability for patients to identify
according to subjective gender rather than as necessarily
“transgender” all encourage unrestrained patient-provider
communication, whereas perceptions of poor provider
knowledge or insensitivity towards transgenderism are
clearly obstructive to disclosure [5,9,15,22]. Participants in
this study described exclusion at the institutional level
mostly in terms of passive erasure, whereby policies fail to
adequately accommodate trans identities [13]. Notably, one
important example of active erasure was mentioned—the
reluctance one participant encountered from her institution
when establishing a clinic to accommodate trans patients.
Trans-focused and trans-friendly care models address trans
patients in relation to their healthcare needs, whether these
needs are transition related or not. Presumably, either
model would result in forms of reverse erasure at the
institutional level by acknowledging trans patients and
adapting health systems to accommodate them. The present
study found support for both models but, given its
exploratory nature, questions regarding which model would
result in better care provision were out of scope.
Several limitations of the present study should be
mentioned. Of the thirteen participants, five had no
known clinical contact with a trans patient, although all
were cognisant of the possibility that they had cared for
a trans patient unaware. Since we were interested in
perspectives on provision barriers amongst physicians
with known trans patients as well as those without, no
attempt was made to exclude the latter. Less experienced
participants described barriers in accessing resources,
medical knowledge, and those related to the organisation
of the healthcare system, but often could not give
specific examples. Only experienced participants provided
insight into barriers regarding GID diagnosis and the ethics
involved with transition-related medical treatments.
Regarding participant recruitment, we initially approached
physicians known by two of the authors to have an interest
in trans healthcare, and physician contacts from a trans
support group. Non-medical group members suggested
physicians who either had expertise or interest in trans
healthcare, or who were perceived to be open to trans
patients. Additional contacts were solicited from the partici-
pants themselves during interviews. This presents issues
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contacts share similar ideas regarding healthcare barriers.
The exploratory nature of the study justified the
recruitment of physicians from different clinical back-
grounds with varying degrees of trans patient exposure, as
our aim was to identify some of the physician-side barriers
to caring for trans patients and strategies for addressing
these. However, because of select participant recruitment, it
is likely that additional barriers and strategies remain
unidentified. An additional limitation was the number of
participants. Recruitment continued until thematic areas no
longer expanded with additional data. However, given the
small number of physicians identified as having a specific
interest in trans healthcare, and the limited experiences
amongst other physician participants, our study drew from
a small sample size.
Conclusions
This exploratory study provides a novel inquiry into
physician-side barriers to healthcare provision for trans
patients. Barriers previously identified by the trans
community were found to limit care provision by physicians
as well, including the inaccessibility of resources and
appropriate referrals, inadequate medical knowledge and
training, the limitations of GID diagnosis, and the low
availability of trans healthcare services. This study presents
additional insight to physician-side barriers involving the
ethics of providing transition-related medical care. The
findings contribute to an emerging debate regarding models
of trans healthcare organisation, and how these may address
some of the barriers faced by trans people and their
physicians within the healthcare system. While the findings
of this study elucidate some of the barriers faced by
physicians, more research is needed to fully understand
healthcare provision barriers, and to develop solutions that
are acceptable to both the medical and trans communities.
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